Bayer unveils a faster-acting aspirin

May 29, 2011

Bayer AG is looking for a speedy remedy for stagnant aspirin sales. The company is introducing a reformulated aspirin today that works in half the time of its regular aspirin.

Bayer says it needed to revitalize the brand and target younger customers to improve its 14.6 percent .

Scientists at Bayer Consumer Care’s Morristown, N.J., headquarters worked for five years to address consumers’ top complaint: The aspirin doesn’t work fast enough.

Bayer Advanced Aspirin was tested in multiple sites on dental patients who had just had wisdom teeth extracted. The company said 500 milligrams of the new aspirin started working in 16 minutes and brought “meaningful pain relief’’ in 49, on average, compared with 100 minutes for the same dose of regular aspirin. Bayer is arranging to publish its research. It has not tested the aspirin against other pain relievers.

In 1988, was approved in low doses to prevent heart attacks and strokes. As a result, “people have kind of forgotten about the fact that is our heritage,’’ said Barton Warner, a Bayer executive.

Analyst Linda Bannister expects Bayer Advance to be a tough sell: Sales of store brand aspirins are growing steadily.

Explore further: FDA OKs Cubist antibiotic for serious infections

2.5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

Study compares formulations of 3 aspirin types

May 15, 2009

For many years, it has been known that aspirin is beneficial to patients suffering heart attacks and near-heart attacks. But which of the many different types of aspirin is likely to help the most?

Aspirin resistant proteins are identified

Jun 26, 2007

Spanish scientists have identified blood proteins that might create aspirin resistance that keeps thousands of people from reaping aspirin's benefits.

Study: Aspirin good for men and women

Jan 17, 2006

A Duke University study suggests aspirin significantly reduces the risk of stroke, heart attack or death due to cardiovascular disease in men and women.

Recommended for you

Express Scripts turns to AbbVie in huge hepatitis C deal

5 hours ago

The nation's largest pharmacy benefits manager is throwing its weight into a fight over the high cost of treating hepatitis C, saying it will cover a new drug from AbbVie while pulling back on more expensive ...

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

dogbert
not rated yet May 29, 2011
I wonder why the work on a drug which costs pennies, unless they think they can patent the modified drug and get people to pay a premium price.

49 minutes versus 100 minutes.

Ibuprophen works in about 40 minutes, 20 to 30 minutes if ingested in a liquid gel. I don't see a large market for aspirin for pain relief, but it will continue to be the drug of choice to reduce clots and for the initial treatment of a clot.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.